Fri, Apr 18, 2014, 11:24 PM EDT - U.S. Markets closed for Good Friday


% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • voclrmet voclrmet Dec 19, 2013 10:46 AM Flag

    VRTX shows great growth potential.

    VRTX shows great growth potential. Strong technical buying signal at stoxline website with the $82.57 target price in six months.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • That's in fact not good new. Current price is 70$ plus, and target of $82.57?? Often target prices are 10-20% exaggerated. In addition, a target price of $82.57? What model did they use to predict to the cent?? Any people with science background know this is a joke. A simple $83 target would be more convincing.

      Overall, very volatile stock. GLTA

      • 1 Reply to haimiao2009
      • johnf50 Dec 19, 2013 11:39 AM Flag

        You are right on Haimiao. Technical price targets are pure speculation. What I have found very reliable though is to use fundamental analysis discounted for risks to determine a range of prices. The technical movements almost always move within those ranges. When they don't, clearly someone has missed something and that is where insight is usually found.

        Secondly, I have found Eastern TA to be far more reliable than Western TA. I highly recommend "Japanese Candlestick Charting Techniques" - Nison.

        That said, $82.57 is BS, $83 is too low... and today's pick up volume on the news is very impressive. VERY BULLISH.

        My opinion this goes higher... in fact, I speculate an anticipation accumulation back into the prior high ranges $85 to $90 by the end of 1Q:14.

        ~ J

        Sentiment: Buy

64.17-0.22(-0.34%)Apr 17 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.